Literature DB >> 14663461

Severe neutropenia among healthy volunteers given rifabutin in clinical trials.

Glen Apseloff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663461     DOI: 10.1016/j.clpt.2003.08.008

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

1.  Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART.

Authors:  Holly E Rawizza; Kristin M Darin; Regina Oladokun; Biobele Brown; Babatunde Ogunbosi; Nkiruka David; Sulaimon Akanmu; Oluremi Olaitan; Charlotte Chang; Kimberly K Scarsi; Prosper Okonkwo; Phyllis J Kanki
Journal:  J Antimicrob Chemother       Date:  2019-09-01       Impact factor: 5.790

Review 2.  A new look at anti-Helicobacter pylori therapy.

Authors:  Seng-Kee Chuah; Feng-Woei Tsay; Ping-I Hsu; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

3.  Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects.

Authors:  Xiaoping Zhang; Scott Fettner; Elke Zwanziger; Lucy Rowell; Miklos Salgo
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

Review 4.  Population screening and treatment of Helicobacter pylori infection.

Authors:  Anthony O'Connor; Colm A O'Morain; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

5.  Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.

Authors:  Vanitha Sekar; Ludo Lavreys; Tom Van de Casteele; Cindy Berckmans; Sabrina Spinosa-Guzman; Tony Vangeneugden; Martine De Pauw; Richard Hoetelmans
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

6.  Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case.

Authors:  Aspasia Katragkou; Charalampos Antachopoulos; Elpis Hatziagorou; Maria Sdougka; Emmanuel Roilides; John Tsanakas
Journal:  Eur J Pediatr       Date:  2012-08-21       Impact factor: 3.183

7.  Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.

Authors:  Amanda M Healan; J McLeod Griffiss; Howard M Proskin; Mary Ann O'Riordan; Wesley A Gray; Robert A Salata; Jeffrey L Blumer
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

8.  Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers.

Authors:  Charles J L la Porte; John P Sabo; Mabrouk Elgadi; D William Cameron
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

9.  Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.

Authors:  Christophe Schmitt; Myriam Riek; Katie Winters; Malte Schutz; Susan Grange
Journal:  Arch Drug Inf       Date:  2009-03

10.  The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012.

Authors:  Chao-Hung Kuo; Fu-Chen Kuo; Huang-Ming Hu; Chung-Jung Liu; Sophie S W Wang; Yen-Hsu Chen; Ming-Chia Hsieh; Ming-Feng Hou; Deng-Chyang Wu
Journal:  Gastroenterol Res Pract       Date:  2012-06-27       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.